$NEWLIMIT - NewLimit's innovative approach to drug discovery, focusing on transcription factors, could lead to rapid medicine development and breakthrough products.
$BIOTECH - The biotech sector shows promise due to its dominant role in early drug discovery and potential for increased revenue per medicine.
$HC - The healthcare sector shows potential for growth due to increasing efficiency in pharmaceuticals and a shift towards preventative medicine, which could reduce overall costs.
$LLY - Eli Lilly's innovative approach with Incredimimetics and the launch of Lilly Direct demonstrates the company's potential for growth in the pharmaceutical sector.